{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:47Z","timestamp":1793371007718,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaad.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:43:20Z","timestamp":1783467800000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liquid biopsy in cutaneous oncology: Current practice and future directions"],"prefix":"10.1016","author":[{"given":"Sabah","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewunmi O.","family":"Adelaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley Ann","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda M.","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2026.07.005_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.005_bib2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jid.2022.02.021","article-title":"Cell-free DNA in dermatology research","volume":"142","author":"Wiggins","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2026.07.005_bib3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/cells11121901","article-title":"Next-generation sequencing on circulating tumor DNA in advanced solid cancer: swiss army knife for the molecular tumor board? A review of the literature focused on FDA approved test","volume":"11","author":"Vasseur","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.jaad.2026.07.005_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jmoldx.2025.07.004","article-title":"High-specificity detection of UV mutational signatures in circulating tumor DNA for diagnostic classification of cutaneous and unknown primary tumors using FoundationOne Liquid CDx","volume":"27","author":"Mata","year":"2025","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1016\/j.jaad.2026.07.005_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabi\u00e8res","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-022-01710-w","article-title":"Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jaad.2026.07.005_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","article-title":"Circulating tumour cells for early detection of clinically relevant cancer","volume":"20","author":"Lawrence","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","article-title":"Application of exosomes as liquid biopsy in clinical diagnosis","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.jaad.2026.07.005_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cncr.30475","article-title":"Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study","volume":"123","author":"Paulson","year":"2017","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.jaad.2026.07.005_bib11","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/cncr.35314","article-title":"The prognostic value of the Merkel cell polyomavirus serum antibody test: a dual institutional observational study","volume":"130","author":"Miller","year":"2024","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2026.07.005_bib12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.35523","article-title":"A promising frontier of circulating messenger RNA in liquid biopsy: from mechanisms to clinical applications","volume":"157","author":"Li","year":"2025","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.jaad.2026.07.005_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12195-025-00846-1","article-title":"High-throughput metabolomic profiling of skin lesions: comparative study of cutaneous squamous cell carcinoma, basal cell carcinoma, and normal skin via e-biopsy sampling","volume":"18","author":"Louie","year":"2025","journal-title":"Cell Mol Bioeng"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib14","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3390\/ijms25052617","article-title":"Extracellular vesicles as novel diagnostic and therapeutic agents for non-melanoma skin cancer: a systematic review","volume":"25","author":"Seretis","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.jaad.2026.07.005_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/1346-8138.16520","article-title":"Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma","volume":"49","author":"Mizuno","year":"2022","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.07.005_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/dermatopathology12030031","article-title":"Molecular and genetic markers for malignant melanoma: implications for prognosis and therapy","volume":"12","author":"Fleshner","year":"2025","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.jaad.2026.07.005_bib18","first-page":"56","article-title":"Circular RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer","volume":"8","author":"Singh","year":"2025","journal-title":"Canc Drug Resist"},{"key":"10.1016\/j.jaad.2026.07.005_bib19","article-title":"Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2026.07.005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100306","article-title":"Liquid biopsy as a potential tool for diagnosis and clinical monitoring of cutaneous and uveal melanoma","volume":"9","author":"Ferraz","year":"2025","journal-title":"J Liq Biopsy"},{"issue":"3","key":"10.1016\/j.jaad.2026.07.005_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(20)30726-9","article-title":"Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study","volume":"22","author":"Syeda","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1470-2045(25)00139-1","volume":"26","author":"Syeda","year":"2025","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.005_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cancers16061197","article-title":"Harnessing ctDNA in advanced melanoma: a promising tool for informed clinical decisions","volume":"16","author":"Pikturniene","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1158\/1078-0432.CCR-25-2274","article-title":"Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma","volume":"32","author":"Ramelyte","year":"2026","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2026.07.005_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-9773-2_7","article-title":"Validation of circulating tumor DNA assays for detection of metastatic melanoma","volume":"2055","author":"Syeda","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.005_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-024-03040-4","article-title":"Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment","volume":"30","author":"Widman","year":"2024","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jaad.2026.07.005_bib27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/cncr.34716","article-title":"Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients","volume":"129","author":"Eroglu","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2026.07.005_bib28","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1158\/1078-0432.CCR-20-2251","article-title":"Circulating tumor DNA predicts outcome from first-, but not second-line treatment and identifies melanoma patients who may benefit from combination immunotherapy","volume":"26","author":"Marsavela","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2026.07.005_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaoncol.2017.5332","article-title":"Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti\u2013programmed cell death 1 antibodies","volume":"4","author":"Lee","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/annonc\/mdz075","article-title":"Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients","volume":"30","author":"Lee","year":"2019","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2026.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1090","article-title":"Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype","volume":"12","author":"Albrecht","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12967-022-03668-1","article-title":"A novel microRNA signature for the detection of melanoma by liquid biopsy","volume":"20","author":"Sabato","year":"2022","journal-title":"J Transl Med"},{"issue":"17","key":"10.1016\/j.jaad.2026.07.005_bib33","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.7150\/thno.77761","article-title":"Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma","volume":"12","author":"Ruggiero","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-021-01490-9","article-title":"Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma","volume":"21","author":"Serrat\u00ec","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2067944","article-title":"Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis","volume":"11","author":"Carretero-Gonz\u00e1lez","year":"2022","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.jaad.2026.07.005_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2023.10.011","article-title":"Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma","volume":"90","author":"Kim","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"16_suppl","key":"10.1016\/j.jaad.2026.07.005_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.e15034","article-title":"Plasma circulating tumor DNA in patients with cutaneous squamous cell carcinoma: initial experience","volume":"42","author":"Fan","year":"2024","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.jaad.2026.07.005_bib38","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3390\/cancers17132162","article-title":"Serum complement factor H: a marker for progression and outcome prediction towards immunotherapy in cutaneous squamous cell carcinoma","volume":"17","author":"Geidel","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.jaad.2026.07.005_bib39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/cancers17071172","article-title":"Mutational profile of blood and tumor tissue and biomarkers of response to PD-1 inhibitors in patients with cutaneous squamous cell carcinoma","volume":"17","author":"Chang","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.jaad.2026.07.005_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jid.2023.09.002","article-title":"Liquid biopsies in advanced cutaneous squamous cell carcinoma: a systematic review","volume":"144","author":"Tay","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2022.03.020","article-title":"Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma","volume":"87","author":"Park","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"26","key":"10.1016\/j.jaad.2026.07.005_bib42","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1200\/JCO.23.02054","article-title":"Circulating tumor DNA assay detects Merkel cell carcinoma recurrence, disease progression, and minimal residual disease: surveillance and prognostic implications","volume":"42","author":"Akaike","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib44","article-title":"Circulating tumor DNA predicts response after definitive radiation therapy for Merkel cell carcinoma","volume":"11","author":"Murchison","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2026.07.005_bib45","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas","volume":"18","author":"Dus\u00edlkov\u00e1","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2026.07.005_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1230273","article-title":"Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles","volume":"13","author":"Mondal","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100304","article-title":"Differential expression analysis of cutaneous squamous cell carcinoma and basal cell carcinoma proteomic profiles sampled with electroporation-based biopsy","volume":"4","author":"Vitkin","year":"2024","journal-title":"JID Innov"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib48","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1111\/bjd.15508","article-title":"Initial in vitro functional characterization of serum exosomal microRNAs from patients with metastatic basal cell carcinoma","volume":"177","author":"Chang","year":"2017","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2026.07.005_bib49","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/jpm12071136","article-title":"Skin cancer research goes digital: looking for biomarkers within the droplets","volume":"12","author":"Dobre","year":"2022","journal-title":"J Pers Med"},{"issue":"224","key":"10.1016\/j.jaad.2026.07.005_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.jaad.2026.07.005_bib51","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa2304714","article-title":"A cell-free DNA blood-based test for colorectal cancer screening","volume":"390","author":"Chung","year":"2024","journal-title":"N Engl J Med"},{"issue":"6378","key":"10.1016\/j.jaad.2026.07.005_bib52","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.aas9102","article-title":"Cancer detection: seeking signals in blood","volume":"359","author":"Kalinich","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jaad.2026.07.005_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2026.07.005_bib54","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41467-023-44461-y","article-title":"Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jaad.2026.07.005_bib56","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41571-025-01074-2","article-title":"Clinical relevance of extracellular vesicles in cancer\u2014therapeutic and diagnostic potential","volume":"22","author":"Greening","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2026.07.005_bib57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaad.2026.07.005_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.csbj.2018.10.002","article-title":"Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management","volume":"16","author":"Elazezy","year":"2018","journal-title":"Comput Struct Biotechnol J"},{"issue":"19","key":"10.1016\/j.jaad.2026.07.005_bib59","first-page":"5111","article-title":"Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA","volume":"26","author":"Oxnard","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.jaad.2026.07.005_bib60","doi-asserted-by":"crossref","first-page":"295","DOI":"10.15407\/exp-oncology.2024.04.295","article-title":"Application of next-generation sequencing to realize principles of precision therapy in management of cancer patients","volume":"46","author":"Khranovska","year":"2025","journal-title":"Exp Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2026.07.005_bib61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11523-025-01153-5","article-title":"Circulating tumor DNA in advanced EGFRex20+ NSCLC: concordance with tissue biopsy, monitoring of response, and resistance to high-dose osimertinib","volume":"20","author":"Zwierenga","year":"2025","journal-title":"Target Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2026.07.005_bib62","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat Med"},{"issue":"7655","key":"10.1016\/j.jaad.2026.07.005_bib63","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib64","first-page":"709","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"19","author":"Adalsteinsson","year":"2017","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib65","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41467-018-04001-5","article-title":"Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma","volume":"9","author":"Manier","year":"2018","journal-title":"Nat Commun"},{"issue":"7761","key":"10.1016\/j.jaad.2026.07.005_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.jaad.2026.07.005_bib67","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"Seth","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2026.07.005_bib68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.6004\/jnccn.2024.0036","article-title":"NCCN guidelines\u00ae insights: melanoma: cutaneous, version 2.2024","volume":"22","author":"Swetter","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jaad.2026.07.005_bib69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N Engl J Med"},{"issue":"46","key":"10.1016\/j.jaad.2026.07.005_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb3461","article-title":"Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome","volume":"6","author":"Shi","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdermsci.2022.03.004","article-title":"Genomic mutation analysis of circulating tumor DNA in metastatic cutaneous squamous cell carcinoma","volume":"106","author":"Sawamura","year":"2022","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib72","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1186\/s12967-025-06957-7","article-title":"Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab","volume":"23","author":"Vanni","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaad.2026.07.005_bib73","article-title":"Circulating immunosuppressive regulatory T cells predict risk of incident cutaneous squamous cell carcinoma","volume":"8","author":"Rollison","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41698-022-00261-z","article-title":"Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma","volume":"6","author":"Geidel","year":"2022","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"10.1016\/j.jaad.2026.07.005_bib75","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/cancers17101702","article-title":"Current and emerging insights into the causes, immunopathogenesis, and treatment of cutaneous squamous cell carcinoma","volume":"17","author":"Anderson","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.jaad.2026.07.005_bib76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2021.6096","article-title":"Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis","volume":"158","author":"McEvoy","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.07.005_bib77","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1245\/s10434-025-18792-7","article-title":"Outcomes of patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma","volume":"33","author":"Bartlett","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2026.07.005_bib78","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1245\/s10434-025-18670-2","article-title":"Local recurrence following complete surgical excision of primary Merkel cell carcinoma","volume":"33","author":"Kavanagh","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2026.07.005_bib79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: current US incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.07.005_bib80","article-title":"The evolving role of ctDNA in Merkel cell carcinoma: challenges and opportunities","volume":"3","author":"Miller","year":"2025","journal-title":"J Cutan Oncol"},{"issue":"20","key":"10.1016\/j.jaad.2026.07.005_bib81","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.18632\/oncotarget.28080","article-title":"Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma","volume":"12","author":"Doan","year":"2021","journal-title":"Oncotarget"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:26:43Z","timestamp":1793370403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226030707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":80,"alternative-id":["S0190962226030707"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.005","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy in cutaneous oncology: Current practice and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}